Thomas J. Garrity, Director at ANTARES PHARMA, INC. (ATRS), sold 30,000 shares at $3.50 ($105K) on 2017-10-03, disclosed to the SEC on 2017-10-05.
Open-market sale of $105k ATRS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ATRS | SELL | 2021-01-13 | $284K | — | Filing → |
| ATRS | SELL | 2019-12-11 | $183K | — | Filing → |
| ATRS | SELL | 2019-05-03 | $80K | — | Filing → |